Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study will look at the performance capabilities of software for VeinViewer.
This study will look at the performance capabilities of future software for VeinViewer.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| VeinViewer | Experimental | Vascular imaging technology will be used to visualize peripheral vasculature. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| VeinViewer | Device | Updated software on the VeinViewer device will be used to project an image of the vasculature on the skin. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of Participants for Whom Successful Visualization of Vasculature Was Achieved | One day |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Gregory Schears, MD | Christie Medical Holdings, Inc. | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Christie Medical Holdings, Inc. | Memphis | Tennessee | 38104 | United States |
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | VeinViewer | Vascular imaging technology will be used to visualize peripheral vasculature. VeinViewer |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | VeinViewer | Vascular imaging technology will be used to visualize peripheral vasculature. VeinViewer |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Average Age, Years |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Number of Participants for Whom Successful Visualization of Vasculature Was Achieved | Posted | Number | participants | One day |
|
|
Not provided
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | VeinViewer | Vascular imaging technology will be used to visualize peripheral vasculature. VeinViewer |
Not provided
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Clinical Affairs Manager | Christie Medical Holdings, Inc. | 901-721-0330 | christiemedinfo@christiedigital.com |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Standard Deviation |
| Years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Ethnicity (NIH/OMB) | Count of Participants | Participants |
|
| Race (NIH/OMB) | Count of Participants | Participants |
|
| Height | Mean | Standard Deviation | CM |
|
| Weight | Mean | Standard Deviation | kg |
|
| Fitzpatrick | A numerical classification for human skin color: Type I (scores 0-6) Pale white, blond/red hair; blue eyes; freckles - Always burns/never tans. II (7-13) White/fair; blond/red hair; blue/green/hazel eyes - Usually burns/tans minimally. III (14-20) Cream white; fair with any hair/eye color; quite common - Sometimes mild burn/uniformly. IV (21-27) Olive to moderate brown; typical Mediterranean skin tone - Rarely burns/always tans well. V (28-34) Dark brown; South Asian skin types - Very rarely burns/tans very easily. VI (35+) Deeply pigmented dark brown to black - Never burns/tans very easily | Mean | Standard Deviation | Points |
|
|
| 0 |
| 62 |
| 0 |
| 62 |
Not provided
Not provided
Not provided